Dermata Therapeutics Faces Delisting Concerns

Ticker: DRMAW · Form: 8-K · Filed: Jul 7, 2025 · CIK: 1853816

Dermata Therapeutics, Inc. 8-K Filing Summary
FieldDetail
CompanyDermata Therapeutics, Inc. (DRMAW)
Form Type8-K
Filed DateJul 7, 2025
Risk Levelhigh
Sentimentbearish

Sentiment: bearish

Topics: delisting, listing-standards, regulatory

Related Tickers: DRMA

TL;DR

DRMA might get delisted, stock trading could be toast.

AI Summary

Dermata Therapeutics, Inc. filed an 8-K on July 7, 2025, reporting a notice of delisting or failure to meet continued listing standards as of July 2, 2025. The company, incorporated in Delaware with its principal executive offices in San Diego, CA, is in the pharmaceutical preparations industry.

Why It Matters

This filing indicates potential delisting from an exchange, which could significantly impact the liquidity and trading of Dermata Therapeutics' stock.

Risk Assessment

Risk Level: high — A notice of delisting directly threatens the company's ability to remain publicly traded, posing a significant risk to investors.

Key Numbers

  • 001-40739 — SEC File Number (Identifies the company's filing history with the SEC.)

Key Players & Entities

  • Dermata Therapeutics, Inc. (company) — Registrant
  • July 2, 2025 (date) — Earliest event reported
  • July 7, 2025 (date) — Filing date
  • San Diego, CA (location) — Principal executive offices
  • Delaware (location) — State of incorporation

FAQ

What specific listing standard did Dermata Therapeutics fail to meet?

The filing does not specify the exact listing standard that was not met, only that a notice of delisting or failure to satisfy a continued listing rule or standard was issued.

What is the date of the earliest event reported in this 8-K?

The earliest event reported is July 2, 2025.

When was this 8-K form filed with the SEC?

This 8-K form was filed on July 7, 2025.

Where are Dermata Therapeutics' principal executive offices located?

Dermata Therapeutics' principal executive offices are located at 3525 Del Mar Heights Rd., #322, San Diego, CA 92130.

What is the company's SIC code?

The company's Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 7, 2025 regarding Dermata Therapeutics, Inc. (DRMAW).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.